Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedA new page revision label, v3.6.3, was added and the previous label v3.6.2 was removed. This indicates an update to the page's versioning, without changes to the study text or data presented.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, signaling a small patch to the page metadata. No changes to the study content are indicated.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study page now displays a recruitment status indicating no longer enrolling participants. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—are added, alongside a minor label change for Intervention/Treatment and a revision update from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check31 days agoChange DetectedThe page now shows a new revision label, from v3.5.4 to v3.5.5. This signals a metadata update to the page rather than a modification to study details or content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a newer document revision. This is a minor metadata update and does not alter the study content visible to users.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page’s displayed site revision/version was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.